Product Description

NOBIVAC® 2-FeLV has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline leukemia viruses. Duration of immunity is at least 2 years.  Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.
-99.99% reaction-free in ongoing surveillance involving millions of doses1
-Two-year duration of immunity means fewer vaccinations
-Subcutaneous or intramuscular injection
-Initial 1 mL dose administered at 9 weeks of age or older
-Second 1 mL dose administered 3 to 4 weeks later
-Contact your veterinarian or manufacturer for more information on revaccination frequency.
-Available in a 25 x 1 mL dose presentation

WARNINGS:
• Contains gentamicin and amphotericin B as preservatives.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination will not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.